{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["PDE4 inhibitor", "airway smooth muscle", "asthma", "beta-adrenergic receptor agonists", "sinigrin"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32508648", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "05", "Day": "20"}], "Language": ["eng"], "ELocationID": ["723", "10.3389/fphar.2020.00723"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "11", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Sinigrin Enhanced Antiasthmatic Effects of Beta Adrenergic Receptors Agonists by Regulating cAMP-Mediated Pathways.", "Pagination": {"StartPage": "723", "MedlinePgn": "723"}, "Abstract": {"AbstractText": ["Millions of patients suffer from asthma worldwide. However, the first-line drugs used to treat asthma, namely, the beta-adrenergic receptors agonists (\u03b2-agonists), are not recommended for use as monotherapy because of their severe dose-related side effects. This limitation has prompted the search for new therapies, which can be used in conjunction with \u03b2--agonists so that lower doses can be administered. Sinigrin is a major compound found in many antiasthmatic medicinal plants. In this study, we explored the antiasthmatic activity of sinigrin when used in combination with \u03b2-agonists and its underlying mechanism. Sinigrin enhanced the asthma-relieving effects of isoproterenol and reduced the effective isoproterenol dose in an acute-asthma model in guinea pigs. Mechanistically, sinigrin enhanced the cAMP levels induced by \u03b2-agonists by inhibiting PDE4. The resulting increase in cAMP levels stimulated the activity of the downstream effector protein kinase A, which would be expected to ultimately induce the relaxation of airway smooth muscle. In conclusion, sinigrin enhances the asthma-relieving effects of \u03b2-agonists by regulating the cAMP signaling pathway and represents a potential add-on drug to \u03b2-agonists for the treatment of asthma."], "CopyrightInformation": "Copyright \u00a9 2020 Chu, Liu, Lu, Yan, Guo, Chang, Jiang and Bai."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China."}], "LastName": "Chu", "ForeName": "Simeng", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China."}], "LastName": "Liu", "ForeName": "Wenjuan", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China."}], "LastName": "Lu", "ForeName": "Yujie", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China."}], "LastName": "Yan", "ForeName": "Menglin", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School of Tianjin University of Traditional Chinese Medicine, Tianjin, China."}], "LastName": "Guo", "ForeName": "Yingying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School of Tianjin University of Traditional Chinese Medicine, Tianjin, China."}], "LastName": "Chang", "ForeName": "Nianwei", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China."}], "LastName": "Jiang", "ForeName": "Min", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China."}], "LastName": "Bai", "ForeName": "Gang", "Initials": "G"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Al-Sajee D., Yin X., Gauvreau G. M. (2019). An evaluation of roflumilast and PDE4 inhibitors with a focus on the treatment of asthma. Expert Opin. Pharmacother. 20 (5), 609\u2013620. \u00a010.1080/14656566.2019.1570132", "ArticleIdList": ["10.1080/14656566.2019.1570132", "30722707"]}, {"Citation": "Baek S. J., Chun J. M., Kang T. W., Seo Y. S., Kim S. B., Seong B., et al. (2018). Identification of Epigenetic Mechanisms Involved in the Anti-Asthmatic Effects of Descurainia sophia Seed Extract Based on a Multi-Omics Approach. Molecules 23 (11), 2879. \u00a010.3390/molecules23112879", "ArticleIdList": ["10.3390/molecules23112879", "PMC6278437", "30400597"]}, {"Citation": "Barnes P. J. (2011). Biochemical basis of asthma therapy. J. Biol. Chem. 286 (38), 32899\u201332905. \u00a010.1074/jbc.R110.206466", "ArticleIdList": ["10.1074/jbc.R110.206466", "PMC3190895", "21799015"]}, {"Citation": "Billington C. K., Ojo O. O., Penn R. B., Ito S. (2013). cAMP regulation of airway smooth muscle function. Pulm. Pharmacol. Ther. 26 (1), 112\u2013120. \u00a010.1016/j.pupt.2012.05.007", "ArticleIdList": ["10.1016/j.pupt.2012.05.007", "PMC3574867", "22634112"]}, {"Citation": "Brand T., Schindler R. (2017). New kids on the block: The Popeye domain containing (POPDC) protein family acting as a novel class of cAMP effector proteins in striated muscle. Cell Signal 40, 156\u2013165. \u00a010.1016/j.cellsig.2017.09.015", "ArticleIdList": ["10.1016/j.cellsig.2017.09.015", "PMC6562197", "28939104"]}, {"Citation": "Brusselle G. G., Ko F. W. (2019). Prevalence and burden of asthma in China: time to act. Lancet 394 (10196), 364\u2013366. \u00a010.1016/S0140-6736(19)31349-2", "ArticleIdList": ["10.1016/S0140-6736(19)31349-2", "31230827"]}, {"Citation": "Campbell I. A., Middleton W. G., McHardy G. J., Shotter M. V., McKenzie R., Kay A. B. (1977). Interaction between isoprenaline and aminophylline in asthma. Thorax 32 (4), 424\u2013428. \u00a010.1136/thx.32.4.424", "ArticleIdList": ["10.1136/thx.32.4.424", "PMC470643", "201045"]}, {"Citation": "Castillo J. R., Peters S. P., Busse W. W. (2017). Asthma Exacerbations: Pathogenesis, Prevention, and Treatment. J. Allergy Clin. Immunol. Pract. 5 (4), 918\u2013927. \u00a010.1016/j.jaip.2017.05.001", "ArticleIdList": ["10.1016/j.jaip.2017.05.001", "PMC5950727", "28689842"]}, {"Citation": "Cazzola M., Matera M. G., Donner C. F. (2005). Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. Drugs 65 (12), 1595\u20131610. \u00a010.2165/00003495-200565120-00001", "ArticleIdList": ["10.2165/00003495-200565120-00001", "16060696"]}, {"Citation": "Dekkers B. G., Racke K., Schmidt M. (2013). Distinct PKA and Epac compartmentalization in airway function and plasticity. Pharmacol. Ther. 137 (2), 248\u2013265. \u00a010.1016/j.pharmthera.2012.10.006", "ArticleIdList": ["10.1016/j.pharmthera.2012.10.006", "23089371"]}, {"Citation": "Dessauer C. W., Watts V. J., Ostrom R. S., Conti M., Dove S., Seifert R. (2017). International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases. Pharmacol. Rev. 69 (2), 93\u2013139. \u00a010.1124/pr.116.013078", "ArticleIdList": ["10.1124/pr.116.013078", "PMC5394921", "28255005"]}, {"Citation": "Foudi N., Badi A., Amrane M., Hodroj W. (2017). Asthma causes inflammation of human pulmonary arteries and decreases vasodilatation induced by prostaglandin I2 analogs. J. Asthma 54 (10), 1012\u20131018. \u00a010.1080/02770903.2017.1292282", "ArticleIdList": ["10.1080/02770903.2017.1292282", "28306357"]}, {"Citation": "Gerthoffer W. T., Solway J., Camoretti-Mercado B. (2013). Emerging targets for novel therapy of asthma. Curr. Opin. Pharmacol. 13 (3), 324\u2013330. \u00a010.1016/j.coph.2013.04.002", "ArticleIdList": ["10.1016/j.coph.2013.04.002", "PMC3686997", "23639507"]}, {"Citation": "Hsu E., Bajaj T. (2020). Beta 2 Agonists In: StatPearls. Treasure Island (FL): StatPearls Publishing."}, {"Citation": "Huang K., Yang T., Xu J., Yang L., Zhao J., Zhang X., et al. (2019). Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet 394 (10196), 407\u2013418. \u00a010.1016/S0140-6736(19)31147-X", "ArticleIdList": ["10.1016/S0140-6736(19)31147-X", "31230828"]}, {"Citation": "Jie M., Cheung W. M., Yu V., Zhou Y., Tong P. H., Ho J. W. (2014). Anti-proliferative activities of sinigrin on carcinogen-induced hepatotoxicity in rats. PloS One 9 (10), e110145. \u00a010.1371/journal.pone.0110145", "ArticleIdList": ["10.1371/journal.pone.0110145", "PMC4203766", "25329483"]}, {"Citation": "Kumar N., Goldminz A. M., Kim N., Gottlieb A. B. (2013). Phosphodiesterase 4-targeted treatments for autoimmune diseases. BMC Med. 11, 96. \u00a010.1186/1741-7015-11-96", "ArticleIdList": ["10.1186/1741-7015-11-96", "PMC3616808", "23557064"]}, {"Citation": "Lee H. W., Lee C. G., Rhee D. K., Um S. H., Pyo S. (2017). Sinigrin inhibits production of inflammatory mediators by suppressing NF-kappaB/MAPK pathways or NLRP3 inflammasome activation in macrophages. Int. Immunopharmacol. 45, 163\u2013173. \u00a010.1016/j.intimp.2017.01.032", "ArticleIdList": ["10.1016/j.intimp.2017.01.032", "28219839"]}, {"Citation": "Lee H. W., Rhee D. K., Kim B. O., Pyo S. (2018). Inhibitory effect of sinigrin on adipocyte differentiation in 3T3-L1 cells: Involvement of AMPK and MAPK pathways. BioMed. Pharmacother. 102, 670\u2013680. \u00a010.1016/j.biopha.2018.03.124", "ArticleIdList": ["10.1016/j.biopha.2018.03.124", "29604586"]}, {"Citation": "Liu L., Liu T., Li G., Wang Q., Ng T. (2003). Isolation and determination of p-hydroxybenzoylcholine in traditional Chinese medicine Semen sinapis Albae. Anal. Bioanal. Chem. 376 (6), 854\u2013858. \u00a010.1007/s00216-003-1964-4", "ArticleIdList": ["10.1007/s00216-003-1964-4", "12811446"]}, {"Citation": "Liu B., Yang J., Wen Q., Li Y. (2008). Isoliquiritigenin, a flavonoid from licorice, relaxes guinea-pig tracheal smooth muscle in vitro and in vivo: Role of cGMP/PKG pathway. Eur. J. Pharmacol. 587 (1), 257\u2013266. \u00a010.1016/j.ejphar.2008.03.015", "ArticleIdList": ["10.1016/j.ejphar.2008.03.015", "18462716"]}, {"Citation": "Liu X., Luo H. B., Huang Y. Y., Bao J. M., Tang G. H., Chen Y. Y., et al. (2014). new phosphodiesterase-4 inhibitors with an unprecedented skeleton from Selaginella pulvinata. Org. Lett. 16 (1), 282\u2013285. \u00a010.1021/ol403282f", "ArticleIdList": ["10.1021/ol403282f", "24328835"]}, {"Citation": "Lommatzsch M., Virchow J. C. (2014). Severe asthma: definition, diagnosis and treatment. Dtsch Arztebl. Int. 111 (50), 847\u2013855. \u00a010.3238/arztebl.2014.0847", "ArticleIdList": ["10.3238/arztebl.2014.0847", "PMC4357024", "25585581"]}, {"Citation": "Lowhagen O. (2015). Diagnosis of asthma - new theories. J. Asthma 52 (6), 538\u2013544. \u00a010.3109/02770903.2014.991971", "ArticleIdList": ["10.3109/02770903.2014.991971", "25478896"]}, {"Citation": "Mazumder A., Dwivedi A., du Preez J. L., du Plessis J. (2016). In vitro wound healing and cytotoxic effects of sinigrin-phytosome complex. Int. J. Pharm. 498 (1-2), 283\u2013293. \u00a010.1016/j.ijpharm.2015.12.027", "ArticleIdList": ["10.1016/j.ijpharm.2015.12.027", "26706438"]}, {"Citation": "Morgan S. J., Deshpande D. A., Tiegs B. C., Misior A. M., Yan H., Hershfeld A.\u00a0V., et al. (2014). \u03b2-Agonist-mediated relaxation of airway smooth muscle is protein kinase A-dependent. J. Biol. Chem. 289 (33), 23065\u201323074. \u00a010.1074/jbc.M114.557652", "ArticleIdList": ["10.1074/jbc.M114.557652", "PMC4132805", "24973219"]}, {"Citation": "Myou S., Fujimura M., Kamio Y., Hirose T., Kita T., Tachibana H. (2003). Bronchodilator effects of intravenous olprinone, a phosphodiesterase 3 inhibitor, with and without aminophylline in asthmatic patients. Br. J. Clin. Pharmacol. 55 (4), 341\u2013346. \u00a010.1046/j.1365-2125.2003.01760.x", "ArticleIdList": ["10.1046/j.1365-2125.2003.01760.x", "PMC1884231", "12680881"]}, {"Citation": "Palazzolo G., Horvath P., Zenobi-Wong M. (2012). The flavonoid isoquercitrin promotes neurite elongation by reducing RhoA activity. PloS One 7 (11), e49979. \u00a010.1371/journal.pone.0049979", "ArticleIdList": ["10.1371/journal.pone.0049979", "PMC3510166", "23209630"]}, {"Citation": "Parikh N., Chakraborti A. K. (2016). Phosphodiesterase 4 (PDE4) Inhibitors in the Treatment of COPD: Promising Drug Candidates and Future Directions. Curr. Med. Chem. 23 (2), 129\u2013141. 10.2174/0929867323666151117121334", "ArticleIdList": ["10.2174/0929867323666151117121334", "26572614"]}, {"Citation": "Philipson L. H. (2002). beta-Agonists and metabolism. J. Allergy Clin. Immunol. 110 (6 Suppl), S313\u2013S317. \u00a010.1067/mai.2002.129702", "ArticleIdList": ["10.1067/mai.2002.129702", "12464941"]}, {"Citation": "Scheinin M., Koulu M., Laurikainen E., Allonen H. (1987). Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Br. J. Clin. Pharmacol. 24 (5), 645\u2013653. 10.1111/j.1365-2125.1987.tb03224.x", "ArticleIdList": ["10.1111/j.1365-2125.1987.tb03224.x", "PMC1386337", "2829953"]}, {"Citation": "Sham T. T., Yuen A. C., Ng Y. F., Chan C. O., Mok D. K., Chan S. W. (2013). A review of the phytochemistry and pharmacological activities of raphani semen. Evid. Based Complement Alternat. Med. 2013, 636194. \u00a010.1155/2013/636194", "ArticleIdList": ["10.1155/2013/636194", "PMC3723324", "23935670"]}, {"Citation": "Suissa S., Dell'Aniello S., Ernst P. (2017). Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study. Chest 151 (1), 60\u201367. \u00a010.1016/j.chest.2016.08.001", "ArticleIdList": ["10.1016/j.chest.2016.08.001", "27554300"]}, {"Citation": "Townsend E. A., Emala C. W. S. (2013). Quercetin acutely relaxes airway smooth muscle and potentiates \u03b2-agonist-induced relaxation via dual phosphodiesterase inhibition of PLC\u03b2 and PDE4. Am. J. Physiol. Lung Cell. Mol. Physiol. 305 (5), L396\u2013L403. \u00a010.1152/ajplung.00125.2013", "ArticleIdList": ["10.1152/ajplung.00125.2013", "PMC3763034", "23873842"]}, {"Citation": "Zafar G. A., Zulfiqar H. (2020). Aminophylline. In: StatPearls. Treasure Island (FL): StatPearls Publishing;"}, {"Citation": "Zhang X., Chen Y., Fan L., Ye J., Fan J., Xu X., et al. (2018). Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap. Drug Des. Devel. Ther. 12, 2371\u20132379. \u00a010.2147/DDDT.S165161", "ArticleIdList": ["10.2147/DDDT.S165161", "PMC6078181", "30122895"]}, {"Citation": "Zuo H., Cattani-Cavalieri I., Musheshe N., Nikolaev V. O., Schmidt M. (2019). Phosphodiesterases as therapeutic targets for respiratory diseases. Pharmacol. Ther. 197, 225\u2013242. \u00a010.1016/j.pharmthera.2019.02.002", "ArticleIdList": ["10.1016/j.pharmthera.2019.02.002", "30759374"]}]}], "History": [{"Year": "2019", "Month": "12", "Day": "3"}, {"Year": "2020", "Month": "4", "Day": "30"}, {"Year": "2020", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "9", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "5", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["32508648", "PMC7251054", "10.3389/fphar.2020.00723"]}}]}